184 related articles for article (PubMed ID: 19861405)
1. RhoC expression and head and neck cancer metastasis.
Islam M; Lin G; Brenner JC; Pan Q; Merajver SD; Hou Y; Kumar P; Teknos TN
Mol Cancer Res; 2009 Nov; 7(11):1771-80. PubMed ID: 19861405
[TBL] [Abstract][Full Text] [Related]
2. RhoC regulates cancer stem cells in head and neck squamous cell carcinoma by overexpressing IL-6 and phosphorylation of STAT3.
Islam M; Sharma S; Teknos TN
PLoS One; 2014; 9(2):e88527. PubMed ID: 24533098
[TBL] [Abstract][Full Text] [Related]
3. RhoC GTPase expression as a potential marker of lymph node metastasis in squamous cell carcinomas of the head and neck.
Kleer CG; Teknos TN; Islam M; Marcus B; Lee JS; Pan Q; Merajver SD
Clin Cancer Res; 2006 Aug; 12(15):4485-90. PubMed ID: 16899593
[TBL] [Abstract][Full Text] [Related]
4. A definitive role of RhoC in metastasis of orthotopic lung cancer in mice.
Ikoma T; Takahashi T; Nagano S; Li YM; Ohno Y; Ando K; Fujiwara T; Fujiwara H; Kosai K
Clin Cancer Res; 2004 Feb; 10(3):1192-200. PubMed ID: 14871999
[TBL] [Abstract][Full Text] [Related]
5. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.
Islam M; Sharma S; Kumar B; Teknos TN
Oral Oncol; 2013 Aug; 49(8):778-86. PubMed ID: 23648017
[TBL] [Abstract][Full Text] [Related]
7. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
8. Down regulation of RhoC by microRNA-138 results in de-activation of FAK, Src and Erk1/2 signaling pathway in head and neck squamous cell carcinoma.
Islam M; Datta J; Lang JC; Teknos TN
Oral Oncol; 2014 May; 50(5):448-56. PubMed ID: 24565984
[TBL] [Abstract][Full Text] [Related]
9. RhoC, vascular endothelial growth factor and microvascular density in esophageal squamous cell carcinoma.
Zhao ZH; Tian Y; Yang JP; Zhou J; Chen KS
World J Gastroenterol; 2015 Jan; 21(3):905-12. PubMed ID: 25624724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
11. A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC.
Hoshino D; Koshikawa N; Seiki M
J Biol Chem; 2011 Jan; 286(4):3139-48. PubMed ID: 21087931
[TBL] [Abstract][Full Text] [Related]
12. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
13. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
Wang H; Zhao G; Liu X; Sui A; Yang K; Yao R; Wang Z; Shi Q
J Exp Clin Cancer Res; 2010 Sep; 29(1):123. PubMed ID: 20828398
[TBL] [Abstract][Full Text] [Related]
14. Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.
Pan Q; Bao LW; Teknos TN; Merajver SD
Cancer Res; 2006 Oct; 66(19):9379-84. PubMed ID: 17018591
[TBL] [Abstract][Full Text] [Related]
15. The role of RhoC in growth and metastatic capacity of melanoma.
Boone B; Van Gele M; Lambert J; Haspeslagh M; Brochez L
J Cutan Pathol; 2009 Jun; 36(6):629-36. PubMed ID: 19222696
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
[TBL] [Abstract][Full Text] [Related]
17. RNF168 promotes RHOC degradation by ubiquitination to restrain gastric cancer progression via decreasing HDAC1 expression.
Xu Y; Feng Y; Sun Z; Li Q
Biochem Biophys Res Commun; 2021 Jun; 557():135-142. PubMed ID: 33865221
[TBL] [Abstract][Full Text] [Related]
18. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
Wang L; Yang L; Luo Y; Zheng Y
J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
[TBL] [Abstract][Full Text] [Related]
19. Expression of RHOC is associated with metastasis of gastric carcinomas.
Kondo T; Sentani K; Oue N; Yoshida K; Nakayama H; Yasui W
Pathobiology; 2004; 71(1):19-25. PubMed ID: 14555841
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
